A Long-Term Follow-Up and Comprehensive Observation of Risk and Prognosis Factors of Recurrence and Survival After Resection of Hepatocellular Carcinoma (original) (raw)

References

  1. Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001). Estimating the world cancer burden: GLOBOCAN 2000. International Journal of Cancer, 94(2), 153–156.
    Article CAS Google Scholar
  2. Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005). Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 55(2), 74–108.
    Google Scholar
  3. Sherman, M. (2005). Hepatocellular carcinoma: epidemiology, risk factors, and screening [Review]. Seminars in Liver Disease, 25(2), 143–154.
    Article PubMed Google Scholar
  4. Yamamoto, J., Okada, S., Shimada, K., Okusaka, T., Yamasaki, S., Ueno, H., et al. (2001). Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology, 34(4 Pt 1), 707–713.
    Article CAS PubMed Google Scholar
  5. Chen, M. S., Li, J. Q., Zheng, Y., Guo, R. P., Liang, H. H., Zhang, Y. Q., et al. (2006). A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Annals of Surgery, 243(3), 321–328.
    Article PubMed Central PubMed Google Scholar
  6. Jianyong, L., Xuejun, K., Yinnong, Z., Zhiming, Z., Weiping, Y., Qingguo, M., et al.. (2009). Analysis of risk factors influencing intrahepatic recurrence of hepatocellular carcinoma after curative resection. Chinese Journal of Operative Procedures of General Surgery, 3(4), 008–010.
    Google Scholar
  7. Nanashima, A., Abo, T., Hamasaki, K., Wakata, K., Tominaga, T., Hidaka, S., et al. (2011). Perioperative non-tumorous factors associated with survival in HCC patients who underwent hepatectomy. Anticancer Research, 31(12), 4545–4551.
    PubMed Google Scholar
  8. Yang, T., Zhang, J., Lu, J. H., Yang, G. S., Wu, M. C., & Yu, W. F. (2011). Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World Journal of Surgery, 35(9), 2073–2082.
    Article PubMed Google Scholar
  9. Kumar, M., Kumar, R., Hissar, S. S., Saraswat, M. K., Sharma, B. C., Sakhuja, P., et al. (2007). Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: A case-control study of 213 hepatocellular carcinoma patients from India. Journal of Gastroenterology and Hepatology, 22(7), 1104–1111.
    Article PubMed Google Scholar
  10. Schlaeger, C., Longerich, T., Schiller, C., Bewerunge, P., Mehrabi, A., Toedt, G., et al. (2008). Etiology-dependent molecular mechanisms in human hepatocarcinogenesis [Research Support, Non-US Gov’t]. Hepatology, 47(2), 511–520.
    Article CAS PubMed Google Scholar
  11. Schwalbe, M., Ohlenschlager, O., Marchanka, A., Ramachandran, R., Hafner, S., Heise, T., et al. (2008). Solution structure of stem-loop alpha of the hepatitis B virus post-transcriptional regulatory element. Nucleic Acids Research, 36(5), 1681–1689.
    Article CAS PubMed Central PubMed Google Scholar
  12. Memon, K., Kulik, L., Lewandowski, R. J., Wang, E., Ryu, R. K., Riaz, A., et al. (2012). Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis [Research Support, N.I.H., Extramural]. Journal of Hepatology, 56(5), 1112–1120.
    Article CAS PubMed Central PubMed Google Scholar
  13. Yang, H. I., Lu, S. N., Liaw, Y. F., You, S. L., Sun, C. A., Wang, L. Y., et al. (2002). Hepatitis B e antigen and the risk of hepatocellular carcinoma [Research Support, Non-US Gov’t]. The New England Journal of Medicine, 347(3), 168–174.
    Article CAS PubMed Google Scholar
  14. Kubo, S., Hirohashi, K., Tanaka, H., Tsukamoto, T., Shuto, T., Yamamoto, T., et al. (2000). Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma [Research Support, Non-US Gov’t]. Cancer, 88(5), 1016–1024.
    Article CAS PubMed Google Scholar
  15. Kubo, S., Hirohashi, K., Yamazaki, O., Matsuyama, M., Tanaka, H., Horii, K., et al. (2002). Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B [Research Support, Non-US Gov’t]. World Journal of Surgery, 26(5), 555–560.
    Article PubMed Google Scholar
  16. Yang, P., Li, Q. J., Feng, Y., Zhang, Y., Markowitz, G. J., Ning, S., et al. (2012). TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell, 22(3), 291–303.
    Article CAS PubMed Central PubMed Google Scholar
  17. Kaibori, M., Tanigawa, N., Matsui, Y., Kwon, A. H., Sawada, S., & Kamiyama, Y. (2004). Preoperative chemolipiodolization of the whole liver for hepatocellular carcinoma [Clinical Trial Randomized Controlled Trial]. Anticancer Research, 24(3b), 1929–1933.
    CAS PubMed Google Scholar
  18. Ohata, K., Hamasaki, K., Toriyama, K., Ishikawa, H., Nakao, K., & Eguchi, K. (2004). High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Journal of Gastroenterology and Hepatology, 19(6), 670–675.
    Article PubMed Google Scholar
  19. Hanazaki, K., Kajikawa, S., Shimozawa, N., Mihara, M., Shimada, K., Hiraguri, M., et al. (2000). Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. Journal of the American College of Surgeons, 191(4), 381–388.
    Article CAS PubMed Google Scholar
  20. Capussotti, L., Muratore, A., Amisano, M., Polastri, R., Bouzari, H., & Massucco, P. (2005). Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival—A European single center experience. European Journal of Surgical Oncology, 31(9), 986–993.
    Article CAS PubMed Google Scholar
  21. Hanazaki, K., Matsushita, A., Nakagawa, K., Misawa, R., & Amano, J. (2005). Risk factors of long-term survival and recurrence after curative resection of hepatocellular carcinoma. Hepato-Gastroenterology, 52(62), 552–557.
    PubMed Google Scholar
  22. Peng, S. Y., Chen, W. J., Lai, P. L., Jeng, Y. M., Sheu, J. C., & Hsu, H. C. (2004). High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and beta-catenin mutations [Research Support, Non-US Gov’t]. International Journal of Cancer Journal International du Cancer, 112(1), 44–50.
    Article CAS PubMed Google Scholar
  23. Tung-Ping Poon, R., Fan, S. T., & Wong, J. (2000). Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma [Review]. Annals of Surgery, 232(1), 10–24.
    Article CAS PubMed Central PubMed Google Scholar
  24. Leone, N., & Rizzetto, M. (2005). Screening for hepatocellular carcinoma] [Review. _Minerva Medica,_ _96_(2), 95–108. ita.
    CAS PubMed Google Scholar
  25. Ren, F. Y., Piao, X. X., & Jin, A. L. (2006). Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma [Evaluation Studies]. World Journal of Gastroenterology, 12(29), 4656–4659.
    PubMed Google Scholar
  26. Soresi, M., Magliarisi, C., Campagna, P., Leto, G., Bonfissuto, G., Riili, A., et al. (2003). Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma [Research Support, Non-US Gov’t]. Anticancer Research, 23(2C), 1747–1753.
    CAS PubMed Google Scholar
  27. Tateishi, R., Yoshida, H., Matsuyama, Y., Mine, N., Kondo, Y., & Omata, M. (2008). Diagnostic accuracy of tumor markers for hepatocellular carcinoma: A systematic review. Hepatology International, 2(1), 17–30.
    Article PubMed Central PubMed Google Scholar
  28. Weiju, S. (2007). Alpha-fetoprotein changing and tumor recurrence after liver transplantation for patients with hepatocellular carcinoma. Hangzhou: Zhejiang University.
    Google Scholar
  29. Hui-chuan, S., Wei, Z., Lun-xiu, Q., Qing-hai, Y., Lu, W., Ning, R., et al. (2007). Effect of preoperative serum HBeAg status on recurrence and survival in hepatocellular carcinoma patients after radical Resection. Chinese Journal of Bases and Clinics in General Surgery, 14, 32–37.
    Google Scholar
  30. Poon, R. T., Fan, S. T., Ng, I. O., Lo, C. M., Liu, C. L., & Wong, J. (2000). Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer, 89(3), 500–507.
    Article CAS PubMed Google Scholar
  31. Ochiai, T., Ikoma, H., Okamoto, K., Kokuba, Y., Sonoyama, T., & Otsuji, E. (2012). Clinicopathologic features and risk factors for extrahepatic recurrences of hepatocellular carcinoma after curative resection. World Journal of Surgery, 36(1), 136–143.
    Article PubMed Google Scholar

Download references